Cargando…

IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION

Detalles Bibliográficos
Autores principales:	Wadud, Nafisa, Ahmed, Naim, Shergill, Mannu, Khan, Maida, Krishna, Murali, Gilani, Aamir, El Zarif, Samer, Galaydick, Jodi, Linga, Karthika, Kooragayalu, Shravan, Galea, Julia, Stuczynski, Lauren, Osundele, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2020
Materias:	Critical Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548660/ http://dx.doi.org/10.1016/j.chest.2020.08.654

Ejemplares similares

CLINICAL OUTCOMES, COMPARISON, AND CHARACTERISTICS AMONG PATIENTS WHO WERE INTUBATED, NONINTUBATED COVID-19 POSITIVE AND INTUBATED COVID-19 NEGATIVE: SINGLE CENTER, RETROSPECTIVE STUDY
por: WADUD, NAFISA, et al.
Publicado: (2021)

Vaping Associated Pulmonary Injury (VAPI) with superimposed Mycoplasma pneumoniae infection
por: Kooragayalu, Shravan, et al.
Publicado: (2020)

Tidal changes on CT and progression of ARDS
por: Cereda, Maurizio, et al.
Publicado: (2017)

TOCILIZUMAB IN COVID-19: EAST-AFRICAN EXPERIENCE
por: SHAH, R., et al.
Publicado: (2022)

ARDS following oesophagectomy: a comparison of two trials
por: Howells, Phillip A, et al.
Publicado: (2017)

MANAGEMENT OF PNEUMOTHORAX AND PNEUMOMEDIASTINUM IN COVID-19 PATIENTS WITH ARDS
por: BAKER, COLBY M., et al.
Publicado: (2022)

EXTRA-CORPOREAL CARBON DIOXIDE REMOVAL IN COVID-19 ARDS
por: Boparai, Sukhmani, et al.
Publicado: (2020)

PROVIDER EXPERIENCE WITH PRONE POSITIONING FOR ARDS DURING COVID-19
por: HOCHBERG, CHAD, et al.
Publicado: (2021)

CHANGES IN ARDS MANAGEMENT AS A RESULT OF THE COVID-19 PANDEMIC
por: MACHURICK, MAXWELL, et al.
Publicado: (2021)

TOCILIZUMAB USE IN SEVERE COVID-19: A SINGLE CENTER EXPERIENCE
por: Poon, Joseph, et al.
Publicado: (2020)

COVID-19 AND A HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME IN THE ABSENCE OF ARDS
por: White, Kyle, et al.
Publicado: (2020)

ENDOTRACHEAL INTUBATION TIMING AND OUTCOME IN ARDS DUE TO COVID-19 INFECTION
por: PEREZ GUTIERREZ, VICTOR, et al.
Publicado: (2021)

ELEVATED D-DIMER PREDICTS DETERIORATION OF ARDS IN PATIENTS WITH COVID-19
por: LOPEZ RUIZ, ARNALDO, et al.
Publicado: (2021)

PROLONGED, PROFOUND UNTREATED HYPOXIA IN COVID-19 ARDS WITH REFUSAL OF TREATMENT
por: THOMAS, KALEB, et al.
Publicado: (2021)

PNEUMOTHORAX, PNEUMOMEDIASTINUM, AND SUBCUTANEOUS EMPHYSEMA IN COVID-19 ARDS: OUR EXPERIENCE
por: FALSINI, L., et al.
Publicado: (2022)

LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
por: GUARDIA, CARLOS G, et al.
Publicado: (2022)

What’s new in ARDS: ARDS also exists in resource-constrained settings
por: Riviello, Elisabeth D., et al.
Publicado: (2016)

Future therapies for ARDS
por: Curley, Gerard F., et al.
Publicado: (2014)

Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS)
por: Dancer, Rachel C A, et al.
Publicado: (2015)

The Effect of Alcohol Consumption on the Risk of ARDS: A Systematic Review and Meta-Analysis
por: Simou, Evangelia, et al.
Publicado: (2018)

A CASE OF PRIAPISM IN A MAN ADMITTED TO THE ICU FOR COVID-19 ARDS
por: ANDERSEN, KARL, et al.
Publicado: (2021)

ARDS From Syndrome to Disease—Treatment Strategies
por: Dries, David J.
Publicado: (2019)

COVID-19-RELATED ARDS PHENOTYPES AND PROGRESSION BETWEEN THEM: A CASE REPORT
por: Steff, Rodney, et al.
Publicado: (2020)

USE OF TISSUE PLASMINOGEN ACTIVATOR IN COVID-19 ARDS: A RETROSPECTIVE CASE SERIES
por: NEMEH, CHRISTOPHER, et al.
Publicado: (2021)

HYPONATREMIA SECONDARY TO VASOPRESSIN IN AN ECMO DEPENDENT PATIENT WITH SEVERE ARDS DUE TO COVID-19
por: HAFEEZ, ZEESHAN, et al.
Publicado: (2021)

DOES EXTRACORPOREAL MEMBRANE OXYGENATION SAVE LIVES IN COVID-19-ASSOCIATED SEVERE ARDS
por: VARGHESE, JOBIN, et al.
Publicado: (2021)

PROPOFOL-RELATED INFUSION SYNDROME IN A PATIENT WITH ARDS SECONDARY TO THE NOVEL COVID-19
por: FREEMAN, HOWARD, et al.
Publicado: (2021)

CORRELATION OF C-REACTIVE PROTEIN (CRP) WITH ICU COVID-19 ARDS MORTALITY IN ADULTS
por: CHANDRAN, RAVI T, et al.
Publicado: (2022)

Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study
por: Spadaro, Savino, et al.
Publicado: (2017)

COMPARISON OF COVID-19 PATIENTS ADMITTED TO THE HOSPITAL WITH ARDS AND THOSE WHO PROGRESS TO IT DURING HOSPITALIZATION
por: IMRAN, MARYAM, et al.
Publicado: (2021)

OUTCOMES OF EXTRACORPOREAL MEMBRANE OXYGENATION IN ARDS DUE TO COVID-19: COMPARISON OF THE FIRST AND THE SECOND WAVE
por: REDDY, ROHIT, et al.
Publicado: (2021)

Fibrinolytic therapy in patients with COVID-19 and ARDS: protocol for a systematic review and meta-analysis
por: Savioli, Felicio, et al.
Publicado: (2023)

Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
por: Menzella, Francesco, et al.
Publicado: (2020)

AIRWAY PRESSURE RELEASE VENTILATION USE IN COVID-19 ARDS: A SINGLE CENTER OBSERVATIONAL STUDY
por: PERINKULAM SATHYANARAYANAN, SWAMINATHAN, et al.
Publicado: (2021)

IMPROVING COMPLIANCE WITH CONTINUOUS ANTERIOR CHEST COMPRESSION IN ARDS CAUSED BY COVID-19: A CASE SERIES
por: PENG, JASON L, et al.
Publicado: (2022)

PRONE POSITIONING IN COVID-19 VS NON-COVID-19 ARDS IN THE EARLY COVID-19 PANDEMIC
por: LIEBERMAN, ALLYSON E, et al.
Publicado: (2022)

Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States: The Severe ARDS: Generating Evidence Study
por: Qadir, Nida, et al.
Publicado: (2021)

German-wide prospective DACAPO cohort of survivors of the acute respiratory distress syndrome (ARDS): a cohort profile
por: Dodoo-Schittko, Frank, et al.
Publicado: (2018)

Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model
por: Cardenes, Nayra, et al.
Publicado: (2019)

SHAKEN, NOT STIRRED: HIGH FREQUENCY PERCUSSIVE VENTILATION AS A SALVAGE THERAPY IN SEVERE ARDS DUE TO COVID-19
por: KHURANA, NEHARIKA, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_clmlhfsakh4h13o493lv8qmarm